Yeon Soo Jeon

The Catholic University of Korea Yeouido St. Mary's Hospital

ORCID: 0000-0002-7677-2002

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “823 | A PHASE IA/IB OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMIC OF UBX‐303061 IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES”.

823 | A PHASE IA/IB OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMIC OF UBX‐303061 IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES

Hematological Oncology(2025)10.1002/hon.70096_823

N/A

0DataRank · unranked

0 citations

Dok Hyun Yoon, Ki‐Seong Eom, Yeon Soo Jeon, Sukhyang Lee, J. Ryu +4 more